Advertisement

Topics

Rheumatoid Arthritis - Pipeline Review, H1 2015

07:44 EDT 11 Aug 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, Rheumatoid Arthritis - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-06-29. This 1135-page report is available in PDF from $2500.

Rheumatoid Arthritis - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Rheumatoid Arthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rheumatoid Arthritis and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Rheumatoid Arthritis
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Rheumatoid Arthritis and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Rheumatoid Arthritis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Rheumatoid Arthritis pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of…

Table of Contents
Table of Contents 2
Introduction 12
Rheumatoid Arthritis Overview 13
Therapeutics Development 14
Rheumatoid Arthritis - Therapeutics under Development by Companies 16
Rheumatoid Arthritis - Therapeutics under Investigation by Universities/Institutes 36
Rheumatoid Arthritis - Pipeline Products Glance 40
Rheumatoid Arthritis - Products under Development by Companies 44
Rheumatoid Arthritis - Products under Investigation by Universities/Institutes 72
Rheumatoid Arthritis - Companies Involved in Therapeutics Development 75
Rheumatoid Arthritis - Therapeutics Assessment 291
Drug Profiles 324
Rheumatoid Arthritis - Recent Pipeline Updates 892
Rheumatoid Arthritis - Dormant Projects 1027
Rheumatoid Arthritis - Discontinued Products 1063
Rheumatoid Arthritis - Product Development Milestones 1074
Appendix 1087

For more information open Rheumatoid Arthritis - Pipeline Review, H1 2015.

SKU: GMDHC6561IDB

Original Article: Rheumatoid Arthritis - Pipeline Review, H1 2015

NEXT ARTICLE

More From BioPortfolio on "Rheumatoid Arthritis - Pipeline Review, H1 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...